NASDAQ
Magenta Therapeutics, Inc. (MGTA) has a current ratio of 13.32x as of Monday, May 25, 2026. This represents a 1.10% increase compared to its 12-month average of 13.18x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.